The NUP214-ABL1 fusion kinase, which is frequently observed in acute lymphoblastic leukemia (ALL), has a vital function in facilitating the cooperative attachment of TLX1 and STAT5 to enhancers, thus triggering the activation of significant oncogenes such as MYC and BCL2 [30]. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.